NCT05185076View on ClinicalTrials.gov

Treatment for Amblyopia Under Binocular Conditions Versus the Standard of Care, Monocular Deprivation Treatment

NAUnknownINTERVENTIONAL

Enrollment

114

Participants

Timeline

Start Date

August 17, 2021

Primary Completion Date

October 26, 2021

Study Completion Date

May 31, 2022

Conditions

Amblyopia

Interventions

DEVICE

CureSight

watch CureSight treatment for 90 minutes per day, 5 days a week for 16 weeks

Trial Locations (2)

Unknown

Rambam medical center, Haifa

Haim Sheba medical center, Ramat Gan

Sponsors

Lead Sponsor

All Listed Sponsors

lead

NovaSight

INDUSTRY

NCT05185076 - Treatment for Amblyopia Under Binocular Conditions Versus the Standard of Care, Monocular Deprivation Treatment | Biotech Hunter | Biotech Hunter